Literature DB >> 20480268

Extravasation of chemotherapy.

Seppo W Langer1.   

Abstract

Extravasation of chemotherapy is a feared complication of anticancer therapy. The accidental leakage of cytostatic agents into the perivascular tissues may have devastating short-term and long-term consequences for patients. In recent years, the increased focus on chemotherapy extravasation has led to the development of international guidelines that have proven useful tools in daily clinical practice. Moreover, the tissue destruction in one of the most dreaded types of extravasation (ie, anthracycline extravasation) now can effectively be prevented with a specific antidote, dexrazoxane.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20480268     DOI: 10.1007/s11912-010-0110-7

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  38 in total

Review 1.  Recognition of a new chemotherapeutic vesicant: trabectedin (ecteinascidin-743) extravasation with skin and soft tissue damage.

Authors:  Todd A Theman; Tristan L Hartzell; Indranil Sinha; Kathleen Polson; Jeffrey Morgan; George D Demetri; Dennis P Orgill; Suzanne George
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544

2.  Distant and delayed mitomycin C extravasation.

Authors:  J S Patel; M Krusa
Journal:  Pharmacotherapy       Date:  1999-08       Impact factor: 4.705

3.  Adriamycin extravasation: surgical treatment and possible prevention of skin and soft-tissue injuries.

Authors:  J Pitkänen; S Asko-Seljavaara; P Gröhn; B Sundell; E Heinonen; P Appelqvist
Journal:  J Surg Oncol       Date:  1983-08       Impact factor: 3.454

4.  Accidental intramuscular injection of mechlorethamine.

Authors:  O E Owen; D L Dellatorre; E J Van Scott; M R Cohen
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

5.  Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies.

Authors:  H T Mouridsen; S W Langer; J Buter; H Eidtmann; G Rosti; M de Wit; P Knoblauch; A Rasmussen; K Dahlstrøm; P B Jensen; G Giaccone
Journal:  Ann Oncol       Date:  2006-12-21       Impact factor: 32.976

6.  Outcome of 350 implanted chest ports placed by interventional radiologists.

Authors:  P C Shetty; M K Mody; D J Kastan; R P Sharma; M W Burke; C Venugopal; T H Burke
Journal:  J Vasc Interv Radiol       Date:  1997 Nov-Dec       Impact factor: 3.464

7.  [Extravasation of paclitaxel (Taxol)].

Authors:  E Raymond; S Cartier; C Canuel; C Louvet; B Demuynck; M Debray; C Varette; S Baux; M Mimoun; A de Gramont
Journal:  Rev Med Interne       Date:  1995       Impact factor: 0.728

8.  Skin ulceration potential of paclitaxel in a mouse skin model in vivo.

Authors:  R T Dorr; K Snead; J D Liddil
Journal:  Cancer       Date:  1996-07-01       Impact factor: 6.860

9.  European Oncology Nursing Society extravasation guidelines.

Authors:  Y Wengström; A Margulies
Journal:  Eur J Oncol Nurs       Date:  2008-09       Impact factor: 2.398

Review 10.  Anthracycline extravasation: a comprehensive review of experimental and clinical treatments.

Authors:  Seppo W Langer; Maxwell Sehested; Peter Buhl Jensen
Journal:  Tumori       Date:  2009 May-Jun
View more
  1 in total

Review 1.  Management of the extravasation of anti-neoplastic agents.

Authors:  J Boulanger; A Ducharme; A Dufour; S Fortier; K Almanric
Journal:  Support Care Cancer       Date:  2015-02-26       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.